0001209191-19-029716.txt : 20190514
0001209191-19-029716.hdr.sgml : 20190514
20190514171558
ACCESSION NUMBER: 0001209191-19-029716
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190512
FILED AS OF DATE: 20190514
DATE AS OF CHANGE: 20190514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Echerd Margaret
CENTRAL INDEX KEY: 0001530193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35285
FILM NUMBER: 19823856
MAIL ADDRESS:
STREET 1: 3585 MONROE STREET
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxart, Inc.
CENTRAL INDEX KEY: 0000072444
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 591212264
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 290 UTAH AVE., SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 550-3500
MAIL ADDRESS:
STREET 1: 290 UTAH AVE., SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Aviragen Therapeutics, Inc.
DATE OF NAME CHANGE: 20160413
FORMER COMPANY:
FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20121113
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20100719
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-12
0
0000072444
Vaxart, Inc.
VXRT
0001530193
Echerd Margaret
C/O VAXART, INC.
290 UTAH AVE. SUITE 200
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
VP, Corporate Controller, PAO
Stock Option (right to buy)
0.77
2019-05-12
4
A
0
70444
0.00
A
2029-05-11
Common Stock
70444
70444
D
The option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares subject to the option vesting in equal monthly installments over the next 36 months.
/s/ Wouter W. Latour, Attorney-in-Fact for Margaret A. Echerd
2019-05-14